However, secondary analyses will be restricted to i patients discharged alive, and ii patients discharged alive in whom these interventions were neither mandated nor contraindicated ie excluding HIV infected children and those with known GP6D deficiency from the cotrimoxazole randomisation, and excluding children admitted for severe acute malnutrition from the supplementation randomisation nolvadex.one - tamoxifen